thyroxine has been researched along with Labhart-Willi Syndrome in 9 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe the response of thyroid-stimulating hormone (TSH) to thyroid-releasing hormone in children and adolescents with Prader-Willi syndrome (PWS), and to compare TSH and total thyroxine (TT4) concentrations measured on neonatal screening for congenital hypothyroidism in children with PWS and controls." | 3.79 | Thyroid function from birth to adolescence in Prader-Willi syndrome. ( Berthier, MT; Chanoine, JP; Deal, C; Deladoëy, J; Giguère, Y; Michaud, S; Sharkia, M; Stewart, L; Van Vliet, G, 2013) |
| "Despite comparable BMI Z-scores and leptin levels, the PWS children exhibited lower fasting insulin and HOMA-IR (homeostasis model assessment of insulin resistance) scores compared to obese controls." | 3.74 | Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. ( Freemark, MS; Grambow, SC; Haqq, AM; Muehlbauer, M; Newgard, CB; Purnell, JQ; Svetkey, LP, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Konishi, A | 2 |
| Koizumi, M | 1 |
| Etani, Y | 2 |
| Ida, S | 2 |
| Kawai, M | 2 |
| Shoji, Y | 1 |
| Sharkia, M | 1 |
| Michaud, S | 1 |
| Berthier, MT | 1 |
| Giguère, Y | 1 |
| Stewart, L | 1 |
| Deladoëy, J | 1 |
| Deal, C | 1 |
| Van Vliet, G | 1 |
| Chanoine, JP | 1 |
| Vaiani, E | 1 |
| Herzovich, V | 1 |
| Chaler, E | 1 |
| Chertkoff, L | 1 |
| Rivarola, MA | 1 |
| Torrado, M | 1 |
| Belgorosky, A | 1 |
| Nyunt, O | 1 |
| Cotterill, AM | 1 |
| Archbold, SM | 1 |
| Wu, JY | 1 |
| Leong, GM | 1 |
| Verge, CF | 1 |
| Crock, PA | 1 |
| Ambler, GR | 1 |
| Hofman, P | 1 |
| Harris, M | 1 |
| Butler, MG | 1 |
| Theodoro, M | 1 |
| Skouse, JD | 1 |
| Haqq, AM | 1 |
| Muehlbauer, M | 1 |
| Svetkey, LP | 1 |
| Newgard, CB | 1 |
| Purnell, JQ | 1 |
| Grambow, SC | 1 |
| Freemark, MS | 1 |
| Festen, DA | 1 |
| Visser, TJ | 1 |
| Otten, BJ | 1 |
| Wit, JM | 1 |
| Duivenvoorden, HJ | 1 |
| Hokken-Koelega, AC | 1 |
| Costeff, H | 1 |
| Holm, VA | 1 |
| Ruvalcaba, R | 1 |
| Shaver, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)[NCT02011360] | 10 participants (Actual) | Interventional | 2014-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for thyroxine and Labhart-Willi Syndrome
| Article | Year |
|---|---|
Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.
Topics: Child; Child, Preschool; Female; Follow-Up Studies; Human Growth Hormone; Humans; Insulin-Like Growt | 2007 |
8 other studies available for thyroxine and Labhart-Willi Syndrome
| Article | Year |
|---|---|
Very young children with Prader-Willi syndrome are refractory to growth hormone-associated decreases in free thyroxine levels.
Topics: Child; Child, Preschool; Female; Human Growth Hormone; Humans; Infant; Male; Prader-Willi Syndrome; | 2023 |
Central hypothyroidism improves with age in very young children with Prader-Willi syndrome.
Topics: Age Factors; Child, Preschool; Humans; Hypothyroidism; Infant; Prader-Willi Syndrome; Retrospective | 2021 |
Thyroid function from birth to adolescence in Prader-Willi syndrome.
Topics: Adolescent; Biomarkers; Case-Control Studies; Child; Child, Preschool; Female; Humans; Hypothyroidis | 2013 |
Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life.
Topics: Female; Humans; Hypothalamo-Hypophyseal System; Infant; Infant, Newborn; Male; Prader-Willi Syndrome | 2010 |
Normal cortisol response on low-dose synacthen (1 microg) test in children with Prader Willi syndrome.
Topics: Adrenocorticotropic Hormone; Australasia; Body Mass Index; Child; Child, Preschool; Cosyntropin; Fem | 2010 |
Thyroid function studies in Prader-Willi syndrome.
Topics: Adolescent; Adult; Child; Female; Humans; Hypothyroidism; Male; Prader-Willi Syndrome; Risk Factors; | 2007 |
Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.
Topics: Adiponectin; Adolescent; Child; Female; Gastric Inhibitory Polypeptide; Ghrelin; Humans; Insulin; In | 2007 |
Growth hormone secretion in Prader-Willi syndrome.
Topics: Child; Female; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Prader-Willi Syndrome; Th | 1990 |